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OBJECTIVES We examined whether delayed post-injection imaging of a new ultrasound contrast agent
(BR-14) could produce prolonged opacification and hyperenhancement of myocardium
subjected to coronary occlusion/reperfusion.
BACKGROUND We hypothesized that ultrasound exposure destroyed BR-14 and eliminated visualization of
sustained myocardial opacification from retained microbubbles.
METHODS We studied eight open-chest dogs with 3 h of left anterior descending coronary artery (LAD)
occlusion followed by 3 h of reperfusion. Myocardial contrast echocardiography (MCE) was
performed before occlusion and 120 min after the onset of both occlusion and reperfusion.
Ultrasound imaging was initiated 15 min after injection. Myocardial blood flow (MBF) was
assessed by microspheres.
RESULTS Pre-occlusion images revealed uniform opacification of left ventricular myocardium greater
than that of the cavity, with a mean intensity of the LAD bed of 8.66  1.38 dB. During
occlusion, MCE resulted in the appearance of a perfusion defect in the LAD risk area
(intensity 2.08  1.10 dB). After 120 min of reperfusion, the LAD risk-area myocardium
manifested dense opacification of a higher intensity (“hot spot”) than baseline (13.7 vs. 8.7
dB), but with reduced MBF consistent with accumulation of a high concentration of
microbubbles. Increased MCE intensity was associated with a greater myeloperoxidase score.
CONCLUSIONS These data establish that contrast opacification by BR-14 may be selectively retained within
the perfusion bed of a coronary artery subjected to occlusion/reperfusion. Such opacification
exhibits defects with occlusion, manifests hyperenhanced intensity (hot spot) with reperfu-
sion, is associated with the level of myeloperoxidase activity, and conforms to the area of
myocardium subjected to altered flow. (J Am Coll Cardiol 2003;42:552–7) © 2003 by the
American College of Cardiology Foundation
Myocardium subjected to coronary occlusion/reperfusion
has characteristically appeared as an opacification defect by
myocardial contrast echocardiography (MCE) (1,2). BR-14
is a recently developed contrast agent that is capable of
producing sustained myocardial opacification after injection
(3). Intravital microscopy has demonstrated that the pro-
longed persistence of BR-14 is due to retention of micro-
bubbles within the capillary bed. However, previous studies
in our laboratory, using a constant infusion of BR-14 with
15 destroy-refill sequences of the cardiac cycle, yielded a
time–intensity curve similar to those curves observed with
conventional, free-flowing microbubble agents (4). We
therefore hypothesized that exposure to ultrasound de-
stroyed BR-14 microbubbles and diminished the ability to
visualize sustained myocardial opacification. We further
speculated that delayed imaging of BR-14 would yield
typical perfusion defects during coronary occlusion, but that
delayed imaging during reperfusion might produce a “hot
spot” of high-intensity opacification in the risk area due to
increased microbubble concentration. In this study, we
quantified the intensity of myocardial opacification pro-
duced by delaying ultrasound imaging for a 15-min interval
after BR-14 injection. We further examined whether such
images would be of value in assessing the risk area of
myocardium exposed to injury in the setting of coronary
occlusion/reperfusion.
METHODS
Animal preparation. The present study was approved by
the Animal Research Committee of the University of
California at San Diego and conformed to the “Position of
the American Heart Association on Research Animal Use.”
Eight mongrel dogs (26.5  1.8 kg) were anesthetized and
ventilated to keep arterial blood gases and pH within
normal limits. The right femoral artery and vein were
cannulated for arterial pressure monitoring and contrast
agent injection, respectively. The heart was exposed through
a left lateral thoracotomy and suspended in a pericardial
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cradle. The proximal portion of the left anterior descending
coronary artery (LAD) was dissected free from the sur-
rounding tissue, and a transit-time flow probe (series 2RB,
Transonics System, Ithaca, New York) connected to a
digital flow meter (model T201, Transonics System) was
placed snugly around the vessel. An atraumatic vascular
clamp produced coronary occlusion of the proximal LAD.
Real-time MCE imaging. Echocardiography was per-
formed with a commercial instrument (HDI 5000, Philips
Ultrasound, Andover, Massachusetts) using a broadband
4-2 MHz transducer. Color-coded harmonic power pulse
inversion images were obtained with ultrasound transmitted
at 2 MHz and received at 4 MHz in the short-axis view at
the papillary muscle level using low-energy (mechanical
index 0.1) real-time imaging at 15 frames/s (5,6). Pulse
repetition frequency was fixed at 2,500 Hz. Instrument
settings were held constant for each experiment. A latex bag
filled with degassed saline functioned as an acoustic inter-
face between the heart and transducer, which was posi-
tioned to image the LAD perfusion territory.
Delayed MCE with BR-14. Using a bolus intravenous
injection of 0.2 ml BR-14 (Bracco Research S.A., Basel,
Switzerland), MCE was performed in eight dogs. BR-14 is
a third-generation ultrasound contrast agent consisting of
perfluorobutane-containing microbubbles stabilized by a
phospholipid monolayer. In two dogs, continuous imaging
was performed after a 15-min delay immediately following
BR-14 injection both before coronary occlusion and after
2 h of reperfusion to determine the duration of opacification
with constant exposure to ultrasound. Additionally, all eight
dogs underwent a protocol in which ultrasound imaging was
terminated at the time of BR-14 injection for a period of 15
min, whereupon 5 to 10 cardiac-cycle digital cine loops were
obtained. To measure real-time MCE signal intensity, the
images were digitally captured and analyzed off-line using
HDI laboratory software. Myocardial signal intensity (dB)
for the first three cardiac cycles was measured from a
25-mm2 region of interest placed in the center of the risk
area, at both lateral margins of the risk area, in an adjacent
normal perfusion area, and in the center of the left ventric-
ular (LV) cavity. The area of abnormal opacification during
occlusion and reperfusion was manually traced for three
end-diastolic images.
Assessment of risk area. The location and size of the
risk-area myocardium was identified during coronary occlu-
sion, both as the unstained region after blue dye injection
and as the region of unopacified myocardium by MCE
during continuous infusion of 0.5 ml/min BR-1 (SonoVue,
Bracco Research S.A.). BR-1 is based on stabilized sulfur
hexafluoride microbubbles, which behave identically to red
blood cells, with a rapid, uninterrupted transit through the
microcirculation. Recordings were obtained 2 min after
initiating infusion to ensure that the plateau intensity had
been reached. To measure the risk-area myocardium from
MCE, frames preceding and following high-energy (me-
chanical index 0.8) “FLASH” frames were digitally cap-
tured. The area of the largest clearly demarcated contrast
defect was manually traced for the final five end-diastolic
images of the 15-cycle FLASH refilling sequence and was
expressed as the mean value.
Myocardial blood flow (MBF) measurements. Myocar-
dial blood flow was measured by standard techniques
employing left atrial injection of fluorescent microspheres
(Molecular Probes, Eugene, Oregon) while reference fem-
oral artery samples were withdrawn. After the animal was
euthanized, the heart was sliced, and the cross-sectional
segment corresponding to the short-axis image was cut into
12 wedge-shaped transmural tissue pieces, each of which
underwent microsphere counting.
Histopathologic evaluation. With the guidance of long
needles placed as markers, a LV short-axis slice 6 to 8 mm
thick was cut out at the same level at which the echocar-
diograms were recorded in three dogs. To determine the
infarct area, each slice was incubated in 1.5% triphenyltet-
razolium chloride (TTC) at 37°C for 15 min, and the
specimen was then fixed in 10% formalin for 48 h for
histologic analysis. In two dogs, blinded quantitative histo-
logic analysis of each segment was also performed by a light
microscopic method with hematoxylin and eosin and my-
eloperoxidase stains. Scores of none (0) to severe (3) for
contraction-band necrosis, interstitial edema, intramyocar-
dial hemorrhage, neutrophil infiltration, coagulation necro-
sis, and myeloperoxidase activity were obtained individually
for each segment. Intracapillary erythrocyte stasis, defined as
the occurrence of capillaries packed with erythrocytes, was
also scored.
Experimental protocol. After a period of stabilization
following instrumentation, baseline hemodynamic and
MCE recordings were performed (Fig. 1). Thirty minutes
after baseline recordings, the proximal LAD was occluded.
Occlusion was maintained for 3 h to produce myocardial
injury, after which time, the clamp was removed and 3 h of
reperfusion was implemented. At 120 min of both occlusion
and reperfusion, MCE was performed. Delayed imaging
was additionally performed in three dogs after 30, 60, 90,
120, and 180 min of reperfusion.
Statistical analysis. Data are expressed as the mean value
 SD. Analyses of the data were performed in a blinded
fashion, without knowledge of any confirmatory data. Com-
parisons of MCE data among all stages were performed
using repeated-measures analysis of variance. Differences
were considered significant at p  0.05.
Abbreviations and Acronyms
LAD  left anterior descending coronary artery
LV  left ventricular
MBF  myocardial blood flow
MCE  myocardial contrast echocardiography
TTC  triphenyltetrazolium chloride
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RESULTS
All experiments were completed successfully without hemo-
dynamic changes or adverse events. Each experiment
yielded technically adequate data for analysis.
Signal intensity from MCE. The MCE data at each stage
are summarized in Table 1. Similar to our previous report,
during continuous imaging, dense opacification filled the
LV cavity immediately after BR-14 injection and was
followed by the subsequent appearance of less intense
signals of relatively uniform distribution within the myocar-
dium (4). For the delayed imaging, LV cavity opacification
was markedly decreased, whereas that of the myocardium
persisted. Therefore, myocardial intensity exceeded that of
the cavity at 15 min (7.8  1.2 vs. 3.0  1.4 dB, p  0.05).
During LAD occlusion, the risk area manifested the antic-
ipated perfusion defect in delayed images, with a marked
reduction in risk area versus normal intensity (2.08  1.10
vs. 7.18  1.54 dB, p  0.05). During reperfusion,
however, the risk-area myocardium manifested a marked
increase in signal intensity relative to the normal region
(13.7  1.2 vs. 8.0  0.6 dB, p  0.05) (Fig. 2). Also, the
signal intensity of the center of the infarction area was
significantly higher than that of noninfarcted border myo-
cardium within the risk area (13.7  1.2 vs. 10.6  1.2 dB,
p  0.05). Following reperfusion, accumulation of micro-
bubbles developed gradually in the reperfused myocardium.
The images after 120 and 180 min of reperfusion revealed
that the LAD risk-area myocardium manifested dense
opacification of a higher intensity than that at baseline
(Table 2). Thus, during reperfusion, the risk-area myocar-
dium was identified as a localized region of dense, bright
opacification, or “hot spot.” Continuous exposure of BR-14
to ultrasound following the delayed imaging protocol re-
sulted in elimination of myocardial opacification after 1 to 2
min of exposure in the both normal and reperfused
myocardium.
Assessment of size of region at-risk area. The location
and size of myocardial segments that manifested decreased
opacification during occlusion and increased intensity dur-
ing reperfusion, as visualized by MCE with BR-14, were
compared with the risk area identified by BR-1 (Table 1).
Figure 1. Delayed myocardial contrast echocardiography (MCE) imaging
(top) and time of events of the protocol (bottom). MBF  myocardial
blood flow.
Table 1. Myocardial Contrast Echocardiographic Data
BR-14 With Delayed Imaging
BR-1 With
Continuous Imaging
Baseline Occlusion Reperfusion Occlusion
Signal intensity (dB)
Normal perfusion area 7.82  1.16 7.18  1.54 7.98  0.62 9.14  2.53
Risk area 8.66  1.38 2.08  1.10* 13.70  1.22* 0.94  0.43*
Margin of risk area 8.67  1.57 4.21  0.89* 10.55  1.17* 1.69  0.47*
LV cavity 2.96  1.39 3.50  1.00 3.70  1.41 22.27  3.56
Risk area size (mm2) 373.9  71.9† 490.4  72.6 490.6  49.3
(defect) (hot spot) (defect)
*p  0.05 versus normal perfusion area. †p  0.05 versus risk area size with BR-1. Data are expressed as the mean value  SD.
LV  left ventricular.
Figure 2. Short-axis myocardial contrast echocardiography images with
BR-14 at baseline (A), during coronary occlusion with BR-1 (B) and
BR-14 (C), and during coronary reperfusion with BR-14 (D). Part D
shows acoustic enhancement of the risk-area myocardium as a “hot spot”
during coronary reperfusion.
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Both the defect and enhanced segments occupied the same
location as the risk area. During coronary occlusion, the
defect size observed with BR-14 was smaller than the risk
area, but no significant difference in size was observed
between the risk area and region with high-intensity signals
during reperfusion (490.6 49.3 vs. 490.4 72.6 mm2). A
comparison of the size of the myocardial region showing
increased intensity with BR-14 during reperfusion and the
risk-area myocardium identified by blue dye injection were
closely correlated (y  0.91x  9.91, r  0.90) (Fig. 3).
Coronary flow and MBF. Data on MBF by microspheres
and LAD flow by Doppler are summarized in Table 3 for
each stage. During LAD occlusion, MBF was severely
reduced within the risk area, but some blood flow from
collateral channels was detectable. During reperfusion, epi-
cardial LAD flow returned to baseline, whereas MBF
within the risk area was reduced from baseline.
Histopathologic analysis. The percentage of infarcted
myocardium measured by TTC of the total risk area,
identified by blue dye, was 43  3%. By light microscopy,
there were no significant differences in contraction-band
necrosis, interstitial edema, or coagulation necrosis between
the center and margins of the infarct area. However, the
degree of intramyocardial hemorrhage, neutrophil infiltra-
tion, myeloperoxidase score, and intracapillary erythrocyte
stasis were higher in the center than in the margin of the
infarct area. A comparison of the myeloperoxidase stain
score and the signal intensity of the hot spot exhibited a
good correlation (Fig. 4).
DISCUSSION
Until now, all microbubble contrast agents have behaved as
free-flowing red blood cells and depicted flow impairment
as perfusion defects. In the present study, we evaluated the
potential of BR-14 to opacify the myocardium after a
15-min ultrasound-free interval following contrast injec-
tion. We observed that the signal intensity ratio of the
normal myocardium to LV cavity exceeded 2.1 at 15 min
after contrast injection, indicating that BR-14 has the
characteristics of prolonged myocardial residence. More-
over, during coronary reperfusion, we observed that delaying
exposure of BR-14 to ultrasound energy produced images
containing a high accumulation of signal intensity in the
risk-area myocardium. Thus, although previous MCE de-
picted occluded/reperfused myocardium as an opacification
defect, BR-14 visualized such myocardium as a hot-spot
region of hyperenhanced, high-intensity signals in the
delayed imaging protocol.
The ability to visualize prolonged myocardial opacifica-
tion by BR-14 is dependent on withholding ultrasound
exposure. Continuous ultrasound imaging with BR-14 re-
sulted in a prompt decrease in myocardial intensity, likely
due to cumulative destruction of circulating microbubbles,
disruption of microbubbles residing within the myocardium,
or a combination of effects. The strategy of deferring
exposure to ultrasound for 15 min and then acquiring
images from the initial cardiac cycles enabled us to amplify
the deposit properties of BR-14, particularly with regard to
reperfused risk-area myocardium. The results obtained by
other ultrasound contrast agents subjected to a similar
imaging protocol are an important area for future research.
The precise mechanism of prolonged myocardial opaci-
fication and post-occlusion/reperfusion hyperenhancement
are not known with certainty. During reperfusion, the
risk-area myocardium manifested dense, high-intensity
opacification consistent with accumulation of a high con-
centration of microbubbles. Because epicardial LAD flow
Table 3. Coronary and Myocardial Blood Flow
Baseline Occlusion Reperfusion
MBF (ml/min per g)
Normal perfusion area 1.40  0.81 1.35  0.53 1.22  0.38
Risk area 1.37  0.44 0.22  0.14* 0.96  0.41*
LAD flow (ml/min) 13.3  4.2 0* 11.8  3.9
*p  0.05 versus baseline. Data are expressed as the mean value  SD.
LAD  left anterior descending coronary artery; MBF  myocardial blood flow.
Table 2. Myocardial Contrast Echocardiographic Signal Intensity Data Within Risk Area
(n  3)
Baseline Occlusion R-30 R-60 R-90 R-120 R-180
8.1  0.7 1.8  0.7* 8.3  0.3 9.5  0.7 10.1  1.5 13.4  0.5* 12.9  1.0*
*p  0.05 versus baseline value. Data are expressed as the mean value  SD in decibels. R-30, 60, 90, 120, and 180 indicate
reperfusion of 30, 60, 90, 120, and 180 min.
Figure 3. Correlation between the size of the myocardial region showing
increased intensity with BR-14 during reperfusion and the risk-area
myocardium identified by blue dye.
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returned to baseline after 120 min of reperfusion, while
MBF within the risk area was reduced from baseline at that
time, persistent hyperemia did not exist within the risk-area
myocardium to deliver more bubbles to the occlusion bed.
Therefore, the increased opacification with BR-14 after
occlusion/reperfusion is most likely primarily due to its
character as a deposit agent rather than to post-occlusion
hyperemia. During nondestructive continuous imaging,
BR-14 can act as a normal, free intravascular tracer, as
reported in our earlier study (4), because microbubbles are
being continuously destroyed. However, in the delayed
MCE imaging approach, BR-14 was observed to produce
prolonged myocardial opacification in the absence of in-
flammation, despite a small size of the microbubbles. In the
setting of normal flow, this deposit property may be related
to retention of bubbles within capillaries due to a net
negative charge and/or complement-mediated attachment
to the endothelium (7). In regions of tissue inflammation
produced by ischemia/reperfusion, lipid layer microbubbles
can adhere to activated leukocytes in post-capillary venules
via cell-surface integrins or opsonization with complement,
resulting in prolonged myocardial opacification throughout
the risk area (8–12). By avoiding bubble destruction, the
delayed MCE imaging protocol may be able to expose the
deposit characteristics of this type of microbubble. In our
study, both the degree of myeloperoxidase stain score and
the signal intensity were higher in the center of the infarct
area than in the margins. These results are consistent with
the concept that increased post-occlusion/reperfusion
opacification is related to the degree of regional myocardial
inflammation (Fig. 4). Thus, high-signal intensity may
indicate inflammation, a condition associated with reperfu-
sion injury and the “no-reflow” phenomenon. It should be
noted that we assessed MCE using a model of 3-h occlusion
and 3-h reperfusion. The ultimate hot-spot signal intensity
may differ with variation of the duration of ischemia.
The perfusion defect area visualized with BR-14 during
coronary occlusion was smaller than the risk area defined by
BR-1. However, the hot-spot size with BR-14 was equal to
the risk area. The risk area includes both infarcted (irrevers-
ible, presumably nonperfused) and ischemic (reversible,
presumably poorly perfused by collateral vessels) tissue.
During occlusion, it is likely that slow, low-volume collat-
eral flow was sufficient to be visualized in the border zone,
thereby yielding a smaller perfusion defect. The spatial
extent of myocardial enhancement during reperfusion with
BR-14 was similar to the risk area identified by blue dye
injection. The acoustic hyperenhancement area with BR-14
during reperfusion was a marker of all abnormal myocar-
dium, both ischemic and infarcted. These data suggest that
inflammation is prevalent in the border zone of the at-risk
myocardium.
Clinical implications. Although we cannot be certain, we
believe that our data may have several possible clinical
implications. If this experimental work can be reproduced in
patients, the ability to produce sustained myocardial opaci-
fication may be of value in imaging and quantifying per-
fusion defects, while simultaneously avoiding problems
associated with signal attenuation. Enhanced signal accu-
mulation during reperfusion might diminish the necessity to
achieve dense opacification in adjacent normal myocardium
in order to detect reduced perfusion or perfusion defects.
We speculate that hot-spot imaging may be an important
area for the research of the no-reflow phenomenon, as well
as inflammation. Finally, the imaging protocol employed in
this study may enable MCE imaging to be performed at
substantial intervals following the injection of ultrasonic
contrast.
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